Antibody-Drug Conjugates (ADC)— Companies & Signals
Antibody-Drug Conjugates (ADCs) represent a sophisticated therapeutic modality that precisely delivers potent chemotherapy agents directly to cancer cells via a targeting antibody, thereby enhancing efficacy and minimizing systemic toxicity. This targeted approach offers a significant advancement in oncology, addressing unmet medical needs and presenting a compelling growth opportunity within the biopharmaceutical sector. 45 public companies above the $50M floor. Last 90 days: 17 red 8-Ks, 0 insider cluster-buys, 8 running hot in the press.
45
Companies
17
Red 8-Ks · 90d
0
Insider clusters
8
🔥 Media-hot
Companies in Antibody-Drug Conjugates (ADC)
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $205.7M | +6.0% | -1.1% | 364K | — | |
| 2 | STRO | SUTRO BIOPHARMA, INC. | Healthcare | $477.2M | +9.3% | +5.7% | 465K | — | |
| 3 | ZYME | Zymeworks Inc. | Healthcare | $1.7B | -0.2% | +3.6% | 1.1M | — | |
| 4 | MGNX | MACROGENICS INC | Healthcare | $251.7M | +1.0% | +6.1% | 1.4M | — | |
| 5 | PYXS | Pyxis Oncology, Inc. | Healthcare | $111.5M | +3.3% | +34.3% | 1.3M | — | red 8-K |
| 6 | IMNM | Immunome Inc. | Healthcare | $2.1B | +5.4% | +9.7% | 1.6M | — | |
| 7 | OSTX | OS Therapies Inc | Healthcare | $75.7M | +19.1% | +23.1% | 2.0M | — | |
| 8 | CTMX | CytomX Therapeutics, Inc. | Healthcare | $655.3M | +10.0% | +23.0% | 7.0M | — | red 8-K |
| 9 | AVBP | ArriVent BioPharma, Inc. | Healthcare | $1.4B | +1.1% | +5.1% | 486K | — | |
| 10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Healthcare | $151.7M | +2.8% | +8.1% | 418K | 🔥 | red 8-K |
| 11 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | $282.7M | +1.2% | +4.3% | 784K | — | |
| 12 | CBIO | CRESCENT BIOPHARMA, INC. | Healthcare | $494.1M | -3.0% | +2.5% | 432K | — | |
| 13 | HURA | TuHURA Biosciences, Inc./NV | Healthcare | $147.7M | +6.0% | -15.5% | 794K | — | red 8-K |
| 14 | BCAX | Bicara Therapeutics Inc. | Healthcare | $1.4B | +9.2% | +19.5% | 1.6M | — | |
| 15 | EXEL | EXELIXIS, INC. | Healthcare | $13.4B | -0.9% | +5.7% | 2.6M | — | red 8-K |
| 16 | MOLN | MOLECULAR PARTNERS AG | Healthcare | $154.2M | +4.2% | +0.3% | 9K | — | |
| 17 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $1.8B | +4.2% | +27.9% | 2.7M | 🔥 | |
| 18 | A | AGILENT TECHNOLOGIES, INC. | Healthcare | $36.7B | -2.3% | +5.0% | 2.0M | 🔥 | red 8-K |
| 19 | XNCR | Xencor Inc | Healthcare | $914.2M | +3.6% | +11.3% | 750K | — | red 8-K |
| 20 | CAI | Caris Life Sciences, Inc. | Healthcare | $5.1B | -1.0% | +5.8% | 3.8M | — | |
| 21 | IBIO | iBio, Inc. | Healthcare | $84.0M | +3.6% | -0.6% | 1.1M | — | red 8-K |
| 22 | LYEL | Lyell Immunopharma, Inc. | Healthcare | $315.0M | +9.8% | +6.5% | 200K | — | |
| 23 | CMPX | Compass Therapeutics, Inc. | Healthcare | $365.6M | +3.9% | +2.9% | 2.8M | — | |
| 24 | SLS | SELLAS Life Sciences Group, Inc. | Healthcare | $1.5B | +24.7% | +81.1% | 33.1M | — | red 8-K |
| 25 | ALLO | Allogene Therapeutics, Inc. | Healthcare | $655.8M | +4.2% | +5.7% | 14.7M | — | red 8-K |
| 26 | RVTY | REVVITY, INC. | Healthcare | $11.1B | -1.6% | +12.3% | 2.0M | 🔥 | |
| 27 | ERAS | Erasca, Inc. | Healthcare | $4.4B | +14.2% | +21.3% | 8.0M | — | |
| 28 | NUVL | Nuvalent, Inc. | Healthcare | $9.8B | -0.0% | +0.1% | 1.3M | 🔥 | |
| 29 | FLGT | Fulgent Genetics, Inc. | Healthcare | $530.5M | +2.9% | +15.1% | 295K | — | red 8-K |
| 30 | ARVN | ARVINAS, INC. | Healthcare | $489.1M | +3.6% | +7.1% | 955K | — | red 8-K |
| 31 | GLSI | Greenwich LifeSciences, Inc. | Healthcare | $353.2M | +17.4% | -2.1% | 208K | — | |
| 32 | MRK | Merck & Co., Inc. | Healthcare | $294.0B | +0.6% | +12.0% | 9.6M | ⚡ | |
| 33 | OMER | OMEROS CORP | Healthcare | $632.2M | +14.3% | -4.1% | 2.7M | — | |
| 34 | NUVB | Nuvation Bio Inc. | Healthcare | $1.7B | -0.7% | -2.6% | 10.7M | — | |
| 35 | GNLX | GENELUX Corp | Healthcare | $132.7M | +1.1% | -0.7% | 200K | — | |
| 36 | AGPU | Axe Compute Inc. | Financials | $76.9M | +5.3% | +5.6% | 215K | — | red 8-K |
| 37 | AZN | ASTRAZENECA PLC | Healthcare | $277.2B | +1.4% | +8.2% | 1.6M | 🔥 | |
| 38 | LEGN | Legend Biotech Corp | Healthcare | $6.7B | +2.4% | +0.2% | 1.3M | ⚡ | |
| 39 | CERT | Certara, Inc. | Technology | $808.9M | +8.9% | +19.1% | 4.9M | — | red 8-K |
| 40 | ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | $266.9M | +14.1% | +25.6% | 2.8M | — | red 8-K |
| 41 | ABBV | AbbVie Inc. | Healthcare | $402.4B | +0.4% | +10.6% | 9.8M | 🔥 | |
| 42 | RXRX | RECURSION PHARMACEUTICALS, INC. | Healthcare | $1.7B | +4.8% | +16.0% | 22.9M | — | red 8-K |
| 43 | WAT | WATERS CORP /DE/ | Healthcare | $34.9B | -1.5% | +3.0% | 981K | ⚡ | |
| 44 | SMMT | Summit Therapeutics Inc. | Healthcare | $10.9B | +2.2% | +0.3% | 6.0M | 🔥 | |
| 45 | CUE | Cue Biopharma, Inc. | Healthcare | $103.0M | +19.9% | -1.0% | 164K | — | red 8-K |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.